Introduction to "Immunotherapies for Multiple Myeloma".
Ontology highlight
ABSTRACT: Multiple myeloma (MM) is the second most common hematological cancer after diffuse large B-cell lymphoma, accounting for about 10% of all blood cancers [...].
SUBMITTER: Offidani M
PROVIDER: S-EPMC7696150 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA